Safety evaluation of the use of calcineurin inhibitor to prenatal and postpartum women in Japan from a health administrative database

Author:

Yashima K.1,Noda A.234,Ishikawa T.5,Matsuzaki F.34,Miyakoda K.6,Nishigori H.7,Mano N.25,Obara T.234

Affiliation:

1. Department of Pharmacy, Tohoku Medical and Pharmaceutical University Wakabayashi Hospital, Sendai, Japan

2. Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan

3. Department of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan

4. Division of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan

5. Laboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan

6. Clinical & Translational Research Center, Kobe University Hospital, Kobe, Japan

7. Fukushima Medical Center for Children and Women, Fukushima Medical University, Fukushima, Japan

Abstract

BACKGROUND: To investigate the use of calcineurin inhibitors (CNIs) in pregnant Japanese women and to evaluate their safety in infants. METHODS: Data were extracted from the claims database of the Japan Medical Data Center. The prevalence of CNIs was evaluated 180 days before pregnancy onset, during pregnancy, and within180-days post partum. We investigated the characteristics of the infants, including the presence of major malformations and their diagnoses, for 1 year after birth. RESULTS: A total of 91,865 pregnancies in 80,049 women were included. Fifty-three women were prescribed CNIs between 180-day before pregnancy onset and 180-day postpartum; 35 of the 53 women were prescribed the drugs during pregnancy, and 10 of their infants were born preterm. Three were diagnosed with major congenital malformations, such as patent ductus arteriosus. Six preterm infants presented with infant respiratory distress syndrome. CONCLUSIONS: No congenital anomalies were clearly attributable to the use of CNIs during pregnancy.

Publisher

IOS Press

Subject

Pediatrics, Perinatology and Child Health

Reference36 articles.

1. Lupus activity in pregnancy;Clowse;Rheum Dis Clin North Am,2007

2. Pregnancy outcomes in women with rheumatic diseases: A real-world observational study in Japan;Sugawara;Lupus,2019

3. Medication use among pregnant women with systemic lupus erythematosus and general population comparators;Palmsten;Rheumatology,2017

4. Drug use before and during pregnancy in Japan: the Japan environment and children’s study;Nishigori;Pharmacy,2017

5. Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: A report of two patients;Izumi;Tohoku J Exp Med,2014

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3